CClinicalTrials.gg
Not yet recruitingNCT07651527BVE-FACTAGEUpdated Jun 16, 2026

Aging Well Together - 'Getting to Know You Better': Characterization of Health FACTors in People Advancing in AGE

An interventional study of Questionnaire and Physical Exam in Aging, Aging Disorder and Aging, Healthy, sponsored by Centre Hospitalier Universitaire de Nice. Not yet recruiting at 1 site in France. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Centre Hospitalier Universitaire de Nice · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
4,500
Allocation
Not applicable
Ages
55 Years and older
Sex
All
01

Study summary

In order to implement effective actions to prevent the loss of autonomy in older adults, which has become a major issue, a crucial first step is to identify the conditions that influence it. Current approaches to health increasingly rely on a comprehensive and multidisciplinary vision, in line with so-called "socio-ecological" approaches, which argue that health is influenced by a wide range of interacting factors. However, these interdependencies and interactions are still poorly understood. It therefore seems necessary to move beyond the isolated analyses of risk factors carried out to date and adopt a holistic/systemic vision by examining both individual and environmental factors, as well as their interactions, which together can contribute to functional decline or the development of pathologies in older adults and those aging.

The aim of this study is to identify the relationships between intrapersonal and environmental factors, and their cumulative, moderating, and mediating effects on the health of older adults and those experiencing aging.

To this end, participants will be asked to complete a series of questionnaires and perform tests on various health-related dimensions. The evaluation criteria are: health, autonomy and quality of life, individual factors (health practices (e.g., physical activity), psychological characteristics (e.g., personal beliefs), socioeconomic status, etc.) and environmental factors (accessibility, living environment).

02

Conditions studied

  • Aging
  • Aging Disorder
  • Aging, Healthy

Browse trials for

Keywords

  • aging
  • physical activity
  • diet
  • environmental factors
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's planned enrollment of 4,500 is above the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Centre Hospitalier Universitaire de Nice is the lead sponsor of 709 studies on the registry; 176 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age 55 or older
  • Affiliation with, or beneficiary of, a social security system
  • No objection to the study

Exclusion criteria

Exclusion Criteria:

  • Individuals protected by law
  • unable to participate in a clinical trial
  • deprived of liberty
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4,500 participants (estimated)

Study arms

  • Experimental
    FACTAGE

    Other: Questionnaire and Physical Exam

Interventions

  • OtherQuestionnaire and Physical Exam

    Questionnaires and tests on health behaviors and health

06

What researchers measure

Primary outcomes

  1. Autonomy

    Autonomy is assessed using the Instrumental Activities of Daily Living (IADL) Scale of Lawton. The scale comprises 8 items. The total score ranges from 0 to 8, with a higher score being better.

    Time frame: at baseline and at 6 months and at 12 months

Secondary outcomes

  1. Care consumption, health behavior and psycho-socio-environmental characteristics

    The evaluation criteria will be, on the one hand, the same individual and environmental factors (e.g., personal beliefs, socio-economic status, accessibility, physical activity, diet) mentioned previously for the main objective, and on the other hand, the consumption of care (number and types of care).

    Time frame: at baseline and at 6 and 12 months

  2. Measure Quality of life

    Quality of life is assessed using the EuroQol at 5 dimensions (EQ-5D) questionnaire. The scale comprises 5 items. Each item is scored from 1 "no problem" to 3 "severe problem". The total score ranges from 5 to 15 with higher score indicating a worse outcome.

    Time frame: at baseline and at 6 months and at 12 months

  3. Physical functional force (physical measure)

    : Physical functional force is assessed using the 5 sit-to-stand test wich consists of asking the participant to stand up and sit down from a chair 5 times as quickly as possible. The outcome is the time taken to complete the test, and the unit of measurement is seconds.

    Time frame: at baseline and at 6 months and at 12 months

  4. Sarcopenia (physical measure)

    Sarcopenia is assessed using the SARC-F questionnaire comprising 5 items assessing force, walk difficulties, stand up capacities, climb stairs capacities and fall. Each item is scored from 0 to 2. The total score ranges from 0 to 10 with higher score indicating a worse outcome.

    Time frame: at baseline and at 6 months and at 12 months

  5. Daily Physical activity Practice (physical behavioral lifestyle measure

    Daily Physical activity Practice is assessed using the Marshall questionnaire comprising 2 items. The total score ranges from 0 to 8. A higher score means a higher level of physical activity. The cut of 4 correspond to "sufficiently active".

    Time frame: at baseline and at 6 months and at 12 months

  6. Subjective cognitive complaint (cognitive measure)

    Subjective cognitive complaint is assessed using items from the ICOPE cohort, regarding the presence and worsening (yes/no) of memory and orientation problems

    Time frame: at baseline and at 6 and 12 months

  7. Body Mass Index (nutritional measure)

    Body Mass Index corresponds to corresponds to weight (kg) divided by height (m) squared. The unit is kg/m2.

    Time frame: at baseline, 6 months later and 12 months

  8. Memory (cognitive measure)

    Memory is assessed using a 3-word recall test. Recalling a word is worth 1 point. A higher score is better.

    Time frame: at baseline, 6 months later and 12 months

  9. Cognitive attention (cognitive measure)

    Cognitive attention is assessed consisting of asking to change the focus of attention. Fewer errors result in a better score

    Time frame: at baseline, 6 months later and 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07651527
Lead sponsor
Centre Hospitalier Universitaire de Nice
Responsible party
Sponsor
First posted
Jun 16, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2031 (estimated)
Completion
Sep 2031 (estimated)
Last update
Jun 16, 2026

Study contacts

Olivier GUERIN, Pr
Contact
guerin.o@chu-nice.fr
0492034194 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion